Accessibility Menu
 
Mycotopia Therapies logo

Mycotopia Therapies

(OTC) TPIA

Current PriceN/A
Market CapN/A
Since IPO (2021)-100%
5 Year-100%
1 Year-95%
1 Month-36%

Mycotopia Therapies Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$2.18K

Net Income (TTM)

$2.22M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

TPIA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mycotopia Therapies

Industry

Healthcare Providers and Services

Employees

1

CEO

Benjamin Kaplan

Headquarters

Aventura, FL 33180, US

TPIA Financials

Key Financial Metrics (TTM)

Gross Margin

-77%

Operating Margin

-845%

Net Income Margin

-1015%

Return on Equity

56%

Return on Capital

47%

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$2.18K

Operating Income

$1.84M

EBITDA

$1.84M

Operating Cash Flow

$458.24K

Capital Expenditure

$0.00

Free Cash Flow

$458.24K

Cash & ST Invst.

$255.94K

Total Debt

$0.00

Mycotopia Therapies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

1

N/A

Net Income

$608.28K

-23.8%

EBITDA

$474.26K

-44.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$255.94K

+123.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-2.53%

N/A

Return on Invested Capital

46.58%

N/A

Free Cash Flow

$86.60K

-401.7%

Operating Cash Flow

$86.60K

-401.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QTXBQuantRx Biomedical Corporation
$0.00+400.00%
MRVTMiravant Medical Technologies Inc.
$0.00+29900.00%
POTNPotNetwork Holdings, Inc.
$0.00+0.00%
PPCBPropanc Biopharma, Inc.
$2.05+20.59%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.74-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$14.20-0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.54+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$74.32-0.01%

Questions About TPIA

What is the current price of Mycotopia Therapies?

Mycotopia Therapies is trading at N/A per share.

What is the 52-week range for Mycotopia Therapies?

Over the past 52 weeks, Mycotopia Therapies has traded between N/A and N/A.

How much debt does Mycotopia Therapies have?

As of the most recent reporting period, Mycotopia Therapies reported total debt of $1.28M.

How much cash does Mycotopia Therapies have on hand?

Mycotopia Therapies reported $255,940 in cash and cash equivalents in its most recent financial results.

What is Mycotopia Therapies’s dividend yield?

Mycotopia Therapies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.